Bleomycin, vincristine, lomustine and dacarbazine (BOLD) in combination with recombinant interferon alpha-2b for metastatic uveal melanoma

By Kivela T.   Suciu S.   Hansson J.   Kruit W.H.J.   Vuoristo M.-S.   Kloke O.   Gore M.   Hahka-Kemppinen M.   Parvinen L.-M.   Kumpulainen E.   Humblet Y.   Pyrhonen S.  

European Journal of Cancer, Vol. 39, Iss. 8, 2003-05 ,pp. : 1115-1120

Elsevier

Access to resources Recommend Favorite

Fotemustine and Dacarbazine Plus Recombinant Interferon Alpha2a in the Treatment of Advanced Melanoma

By Comella P.   Daponte A.   Casaretti R.   Ionna F.   Fiore F.   Presutti F.   Frasci G.   Caponigro F.   Gravina A.   Parziale A.P.   Mozzillo N.   Comella G.  

European Journal of Cancer, Vol. 33, Iss. 8, 1997-07 ,pp. : 1326-1329

Elsevier

Access to resources Recommend Favorite

Treatment of metastatic malignant melanoma with dacarbazine plus fotemustine

By Seeber A.   Binder M.   Steiner A.   Wolff K.   Pehamberger H.  

European Journal of Cancer, Vol. 34, Iss. 13, 1998-12 ,pp. : 2129-2131

Elsevier

Access to resources Recommend Favorite

Subcutaneous Recombinant Interleukin-2 Plus Chemotherapy with Cisplatin and Dacarbazine in Metastatic Melanoma

By Guida M.   Latorre A.   Mastria A.   De Lena M.  

European Journal of Cancer, Vol. 32, Iss. 4, 1996-04 ,pp. : 730-733

Elsevier

Access to resources Recommend Favorite

Long-term survival benefit after adjuvant treatment of cutaneous melanoma with dacarbazine and low dose natural interferon alpha: A controlled, randomised multicentre trial

By Stadler Rudolf   Luger Thomas   Bieber Thomas   Köhler Ulrike   Linse Ruthild   Technau Kristin   Schubert Roland   Schroth Katja   Vakilzadeh Feredoun   Volkenandt Matthias   Gollnick Harald   Von Eick Harald   Thoren Fredrik   Strannegård Örjan  

Acta Oncologica, Vol. 45, Iss. 4, 2006-06 ,pp. : 389-399

Informa Healthcare

Access to resources Recommend Favorite